Mandate

VINGE ADVISES SHANGHAI XINGXUEKANG IVESTMENT PARTNERSHIP IN CONNECTION WITH THE ACQUISITION OF OPCON ENERGY SYSTEMS SVENSAK ROTORMASKINER

July 02, 2015

XingXueKang Investment Partnership has entered into a share purchase agreement with Opcon, the energy and environmental technology group a share purchase agreement concerning the sale of Opcon’s main part of the group’s operations within compressor technology and waste heat recovery. The transaction also includes the newly-formed company, Opcon Compressor Technology AB as well as the subsidiaries Svenska Rotor Maskiner AB, Opcon Energy System AB and 48.9796% of the shares in the jointly owned Chinese company Fuijan Opcon Energy Technology Co. Ltd. The transaction also includes all intellectual property rights related to compressor technology and Opcon Powerbox. The Opcon trademark will also be assigned although it will continue to be used by the Opcon group during a transitional period.

Following completion of the due diligence phase based on the accounts as per 31 March 2015, the purchase price amounts to SEK 400 million. Fifteen per cent of the purchase price will be paid in cash not later than 20 business days after the agreement enters into force following approval by the members at Opcon’s general meeting and approval by the investment committee which controls the purchaser. The remaining 85% of the purchase price shall be paid at closing of the transaction, which is anticipated to occur on 30 September 2015 when title to the shares passes to the purchaser.

Vinge’s team consisted of responsible counsel Qun Gu and Ulrich Ziche (project manager), and Andrea Jägerstedt (M&A), Johan Cederblad, Niclas Winnberg and Julia Nääs (real estate and environmental), Karin Grauers (commercial agreements, IP and IT), Maria Schultzberg (tax), Johan Wahlbom (competition) and project assistants Annika Johnson and Carline Skymberg.

For further information, please see Opcon’s press release: www.opcon.se

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025